1. Home
  2. GANX vs YYGH Comparison

GANX vs YYGH Comparison

Compare GANX & YYGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • YYGH
  • Stock Information
  • Founded
  • GANX 2017
  • YYGH 2010
  • Country
  • GANX United States
  • YYGH Singapore
  • Employees
  • GANX N/A
  • YYGH N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • YYGH
  • Sector
  • GANX Health Care
  • YYGH
  • Exchange
  • GANX Nasdaq
  • YYGH NYSE
  • Market Cap
  • GANX 45.8M
  • YYGH 40.2M
  • IPO Year
  • GANX 2021
  • YYGH 2024
  • Fundamental
  • Price
  • GANX $1.94
  • YYGH $1.20
  • Analyst Decision
  • GANX Strong Buy
  • YYGH
  • Analyst Count
  • GANX 5
  • YYGH 0
  • Target Price
  • GANX $8.20
  • YYGH N/A
  • AVG Volume (30 Days)
  • GANX 314.5K
  • YYGH 79.8K
  • Earning Date
  • GANX 05-13-2025
  • YYGH 05-20-2025
  • Dividend Yield
  • GANX N/A
  • YYGH N/A
  • EPS Growth
  • GANX N/A
  • YYGH N/A
  • EPS
  • GANX N/A
  • YYGH N/A
  • Revenue
  • GANX N/A
  • YYGH $41,103,389.00
  • Revenue This Year
  • GANX N/A
  • YYGH N/A
  • Revenue Next Year
  • GANX N/A
  • YYGH N/A
  • P/E Ratio
  • GANX N/A
  • YYGH N/A
  • Revenue Growth
  • GANX N/A
  • YYGH 29.37
  • 52 Week Low
  • GANX $0.89
  • YYGH $0.72
  • 52 Week High
  • GANX $3.19
  • YYGH $2.14
  • Technical
  • Relative Strength Index (RSI)
  • GANX 54.26
  • YYGH N/A
  • Support Level
  • GANX $1.85
  • YYGH N/A
  • Resistance Level
  • GANX $2.27
  • YYGH N/A
  • Average True Range (ATR)
  • GANX 0.16
  • YYGH 0.00
  • MACD
  • GANX 0.02
  • YYGH 0.00
  • Stochastic Oscillator
  • GANX 59.17
  • YYGH 0.00

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About YYGH YY GROUP HOLDING LIMITED

YY Group Holding Ltd is a data and technology-driven company focused on developing enterprise intelligent labor matching services and smart cleaning services, founded in Singapore. Through its subsidiaries, it provides enterprise manpower outsourcing and smart cleaning services in Singapore, Malaysia, and other countries. The group's reportable segments are Manpower outsourcing services and Cleaning Service. Maximum revenue is generated from the Cleaning Service segment, which is engaged in acting as a contractor to provide long-term cleaning services to hotels and shopping malls, including the areas of toilets, common areas, bin centers, elevators, etc. Geographically, a majority of the group's revenue is generated from its operations in Singapore and Malaysia.

Share on Social Networks: